TIM-3 blockade enhances IL-12-dependent antitumor immunity by promoting CD8 + T cell and XCR1 + dendritic cell spatial co-localization.
Alycia GardnerÁlvaro de Mingo PulidoKay HänggiSarah BazarganAlexis OnimusAgnieszka KasprzakJose R Conejo-GarciaKatarzyna A RejniakBrian H RuffellPublished in: Journal for immunotherapy of cancer (2022)
T cells to cDC1-derived cytokines, with implications for the design of therapeutic strategies using antibodies against TIM-3.